Article
Whole Genome Landscape Analysis of Homologous Recombination Deficiency in a Pan-Cancer Cohort
2024-06-30
Abstract excerpt
<h4>Purpose</h4> Homologous recombination deficiency (HRD) impacts cancer treatment strategies, particularly the effectiveness of PARP inhibitors. However, the variability different HRD assays has hampered the selection of oncology patients who may benefit from these therapies. Our study aims to assess the whole genome landscape to better define HRD in a pan-cancer cohort and to contribute to harmonization of HRD...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ecb92d71-681f-5643-9ced-8e29b191f49f
- DOI
- 10.1101/2024.06.28.24309592
